Bugarin Amador, Schroeder Grant, Shi Brendan Y, Jones Kristofer J, Kremen Thomas J
David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA.
Department of Orthopaedic Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA.
Orthop J Sports Med. 2022 May 26;10(5):23259671221093074. doi: 10.1177/23259671221093074. eCollection 2022 May.
The wide range of clinical applications and controversial scientific evidence associated with platelet-rich plasma (PRP) therapy in musculoskeletal medicine requires an examination of the most commonly cited studies within this field.
To identify the 50 most cited articles on PRP, assess their study design, and determine any correlations between the number of citations and level of evidence (LoE) or methodological quality.
Cross-sectional study.
The Web of Science database was queried to identify the top 50 most cited articles on PRP in orthopaedic surgery. Bibliometric characteristics, number of citations, and LoE were recorded. Methodological quality was evaluated using the Modified Coleman Methodology Score (MCMS), Methodological Index for Non-randomized Studies (MINORS), and Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO). The Pearson correlation coefficient and Spearman correlation coefficient ( ) were used to determine the degree of correlation between the number of citations or citation density and LoE, MCMS, MINORS score, and MIBO score. Student tests were performed for 2-group comparisons.
The top 50 articles were published between 2005 and 2016 in 21 journals. The mean number of citations and citation density were 241 ± 94 (range, 151-625) and 23 ± 8, respectively, and the mean LoE was 2.44 ± 1.67, with 15 studies classified as LoE 1. The mean MCMS, MINORS score, and MIBO score were 66.9 ± 12.6, 16 ± 4.7, and 12.4 ± 3.7, respectively. No correlation was observed between the number of citations or citation density and LoE, MCMS, MINORS score, and MIBO score. A significant difference ( = .02) was noted in LoE in articles from the United States (3.56 ± 1.7) versus outside the United States (2 ± 1.5). Seven of the 8 in vivo studies were published between 2005 and 2010, whereas 19 of the 25 clinical outcome investigations were published between 2011 and 2016. Studies that were published more recently were found to significantly correlate with number of citations ( = -0.38; = .01), citation density ( = 0.36; = .01), and higher LoE ( = 0.47; = .01).
The top 50 most cited articles on PRP consisted of high LoE and fair methodological quality. There was a temporal shift in research from in vivo animal studies toward investigations focused on clinical outcomes.
富含血小板血浆(PRP)疗法在肌肉骨骼医学中的广泛临床应用以及存在争议的科学证据,需要对该领域最常被引用的研究进行审视。
识别关于PRP的50篇被引用次数最多的文章,评估其研究设计,并确定被引用次数与证据水平(LoE)或方法学质量之间的相关性。
横断面研究。
查询科学网数据库,以确定骨科手术中关于PRP的被引用次数最多的前50篇文章。记录文献计量学特征、被引用次数和LoE。使用改良科尔曼方法评分(MCMS)、非随机研究方法学指数(MINORS)和骨科生物制品评估研究的最低信息(MIBO)评估方法学质量。使用皮尔逊相关系数和斯皮尔曼相关系数()来确定被引用次数或引用密度与LoE、MCMS、MINORS评分和MIBO评分之间的相关程度。进行学生检验以进行两组比较。
前50篇文章于2005年至2016年发表在21种期刊上。平均被引用次数和引用密度分别为241±94(范围151 - 625)和23±8,平均LoE为2.44±1.67,其中15项研究被归类为LoE 1级。平均MCMS、MINORS评分和MIBO评分分别为66.9±12.6、16±4.7和12.4±3.7。未观察到被引用次数或引用密度与LoE、MCMS、MINORS评分和MIBO评分之间的相关性。在美国发表的文章与美国以外发表的文章在LoE方面存在显著差异(=0.02)(美国为3.56±1.7,美国以外为2±1.5)。8项体内研究中的7项发表于2005年至2010年,而25项临床结局研究中的19项发表于2011年至2016年。发现较近期发表的研究与被引用次数(= -0.38;=0.01)、引用密度(=0.36;=0.01)以及更高的LoE(=0.47;=0.01)显著相关。
关于PRP的50篇被引用次数最多的文章具有较高的LoE和合理的方法学质量。研究存在从体内动物研究向侧重于临床结局的调查的时间性转变。